Therapeutic Class
ReNAgade takes off with $300m+ to tackle RNA challenges
Therapeutic ClassReNAgade takes off with $300m+ to tackle RNA challengesReNAgade takes off with $300m+ to tackle RNA challenges
The $300 million Series A financing round will support development of an all-RNA delivery platform, says ReNAgade.